glutathione chronic fatigue syndrome deficiency low levels in Myalgic encephalomyelitis /chronic (ME/CFS): diagnosis and management Brain and muscle Glutathione in Chronic Fatigue Syndrome

Psychiatry 13, 889636

Reduced CYP2C9 activity, caused by genetic variation in the CYP2C9 gene, increases systemic exposure to fluvastatin, which can predispose an individual to increased risk of fluvastatin-induced muscle-related adverse events

Mangino G, Famiglietti M, Capone C, Veroni C, Percario ZA, Leone S, Fiorucci G, Llf S, Romeo G, Agresti C, Persichini T, Geyer M, Affabris E

prevent the existence C

Self-reported dose per injection Median bucket: 23 mg Most common: 23 mg Reports span 0 to 5 mg (open-ended top bucket) Anonymized self-reports from PeptIQ users not prescribing guidance

Some research suggests individuals with fatty liver may have reduced hepatic glutathione levels